Skeletal Development

Cell Signaling and Growth Factors in Development: From Molecules to Organogenesis

Volumn 2, Issue , 2008, Pages 619-640

  Horton, William A ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

Author keywords

Endochondral skeletal development; Growth plate structure; Linear growth; Membranous skeletal development; Skeletal morphogenesis

Indexed keywords

EID: 84889782793     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527619689.ch16     Document Type: Chapter

References (114)

1. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C.,. et al., Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
2. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G.,. et al., The sequence of the human genome. Science 2001; 291: 1304-1351.
3. Horton, W.A., Molecular genetic basis of the human chondrodysplasias. Endocrinol Metab Clin North Am 1996; 25: 683-697.
4. Rimoin, D.L., Lachman, R. S. and Unger, S., Chondrodysplasias. In Emery and Remoin's Principles and Practice of Medical Genetics (4th edn), Rimoin, D.L., Connor, J.M., Pyeritz, R. E. and Korf, B. R. (Eds). Churchill Livingstone: New York, 2002, pp. 4071-4115.
5. Zelzer, E. and Olsen, B.R., The genetic basis for skeletal diseases. Nature 2003; 423: 343-348.
6. Erlebacher, A., Filvaroff, E.H., Gitelman, S. E. and Derynck, R., Toward a molecular understanding of skeletal development. Cell 1995; 80: 371-378.
7. Olsen, B.R., Reginato, A. M. and Wang, W., Bone development. Annu Rev Cell Dev Biol 2000; 16: 191-220.
8. Helms, J. A. and Schneider, R.A., Cranial skeletal biology. Nature 2003; 423: 326-331.
9. Murakami, S., Akiyama, H. and de Crombrugghe, B., Development of bone and cartilage. In Inborn Errors of Development, Epstein, C.J., Erickson, R. P. and Winshaw-Boris, A. (Eds). Oxford University Press: New York, 2004, pp. 133-147.
10. Hall, B. K. and Miyake, T., All for one and one for all: condensations and the initiation of skeletal development. Bioessays 2000; 22: 138-147.
11. Mariani, F. V. and Martin, G.R., Deciphering skeletal patterning: clues from the limb. Nature 2003; 423: 319-325.
12. DeLise, A.M., Fischer, L. and Tuan, R.S., Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 2000; 8: 309-334.
13. Hall, B. K. and Miyake, T., The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis. Anat Embryol (Berl) 1992; 186: 107-124.
14. Hall, B. K. and Miyake, T., Divide, accumulate, differentiate: cell condensation in skeletal development revisited. Int J Dev Biol 1995; 39: 881-893.
15. Morriss-Kay, G.M., Derivation of the mammalian skull vault. J Anat 2001; 199: 143-151.
16. Hall, B.K., Development of the clavicles in birds and mammals. J Exp Zool 2001; 289: 153-161.
17. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S. and Kishimoto, T., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-764.
18. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L. and Karsenty, G., Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754.
19. Karsenty, G. and Wagner, E.F., Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002; 2: 389-406.
20. Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., Stamp, G.W., Beddington, R.S., Mundlos, S., Olsen, B.R., Selby, P. B. and Owen, M.J., Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765-771.
21. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S., Albright, S., Lindhout, D., Cole, W.G., Henn, W., Knoll, J.H., Owen, M.J., Mertelsmann, R., Zabel, B. U. and Olsen, B.R., Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 1997; 89: 773-779.
22. Kundu, M., Javed, A., Jeon, J.P., Horner, A., Shum, L., Eckhaus, M., Muenke, M., Lian, J.B., Yang, Y., Nuckolls, G.H., Stein, G. S. and Liu, P.P., Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 2002; 32: 639-644.
23. Yoshida, C.A., Furuichi, T., Fujita, T., Fukuyama, R., Kanatani, N., Kobayashi, S., Satake, M., Takada, K. and Komori, T., Corebinding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 2002; 32: 633-638.
24. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J.M., Behringer, R. R. and de Crombrugghe, B., The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29.
25. St-Jacques, B., Hammerschmidt, M. and McMahon, A.P., Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999; 13: 2072-2086.
26. Ohbayashi, N., Shibayama, M., Kurotaki, Y., Imanishi, M., Fujimori, T., Itoh, N. and Takada, S., FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 2002; 16: 870-879.
27. Long, F., Chung, U.I., Ohba, S., McMahon, J., Kronenberg, H. M. and McMahon, A.P., Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 2004; 131: 1309-1318.
28. Reddi, A.H., Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 1997; 8: 11-20.
29. Capdevila, J. and Izpisua Belmonte, J.C., Patterning mechanisms controlling vertebrate limb development. Annu Rev Cell Dev Biol 2001; 17: 87-132.
30. Wilkie, A. O. and Morriss-Kay, G.M., Genetics of craniofacial development and malformation. Nat Rev Genet 2001; 2: 458-468.
31. Muenke, M., Schell, U., Hehr, A., Robin, N.H., Losken, H.W., Schinzel, A., Pulleyn, L.J., Rutland, P., Reardon, W., Malcolm, S. and et al., A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994; 8: 269-274.
32. Lomri, A., Lemonnier, J., Hott, M., de Parseval, N., Lajeunie, E., Munnich, A., Renier, D. and Marie, P.J., Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. J Clin Invest 1998; 101: 1310-1317.
33. Morris, N.P., Keene, D. R. and Horton, W.A., Morphology and chemical composition of connective tissue: cartilage. In Connective Tissue and its Heritable Disorders (2nd edn), Royce, P. M. and Steinmann, B. (Eds). Wiley: New York, 2002, pp. 41-66.
34. Uhthoff, H.K., Development of the growth plate during intrauterine life. In Behavior of the Growth Plate, Uhthoff, H. K. and Wiley, J. J. (Eds). Raven Press: New York, 1988, pp. 17-24.
35. Ogden, J. A. and Rosenberg, L.C., Defining the growth plate. In Behavior of the Growth Plate, Uhthoff, H. K. and Wiley, J. J. (Eds). Raven Press: New York, 1988, pp. 1-16.
36. Kaufman, M.H., The Atlas of Mouse Development. Academic Press: London, 1992
37. de Crombrugghe, B., Lefebvre, V. and Nakashima, K., Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 2001; 13: 721-727.
38. Bi, W., Deng, J.M., Zhang, Z., Behringer, R. R. and de Crombrugghe, B., Sox9 is required for cartilage formation. Nat Genet 1999; 22: 85-89.
39. Lefebvre, V., Behringer, R. R. and de Crombrugghe, B., L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 2001; 9(Suppl. A): S69-75.
40. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F.D., Keutel, J., Hustert, E. and et al., Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994; 79: 1111-1120.
41. Foster, J.W., Dominguez-Steglich, M.A., Guioli, S., Kowk, G., Weller, P.A., Stevanovic, M., Weissenbach, J., Mansour, S., Young, I.D., Goodfellow, P. N. and et al., Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994; 372: 525-530.
42. Iyama, K., Ninomiya, Y., Olsen, B.R., Linsenmayer, T.F., Trelstad, R. L. and Hayashi, M., Spatiotemporal pattern of type X collagen gene expression and collagen deposition in embryonic chick vertebrae undergoing endochondral ossification. Anat Rec 1991; 229: 462-472.
43. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J.,Werb, Z. and Ferrara, N., VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5: 623-628.
44. Inada, M., Yasui, T., Nomura, S., Miyake, S., Deguchi, K., Himeno, M., Sato, M., Yamagiwa, H., Kimura, T., Yasui, N., Ochi, T., Endo, N., Kitamura, Y., Kishimoto, T. and Komori, T., Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 1999; 214: 279-290.
45. Smits, P., Dy, P., Mitra, S. and Lefebvre, V., Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J Cell Biol 2004; 164: 747-758.
46. Bitgood, M. J. and McMahon, A.P., Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995; 172: 126-138.
47. Vortkamp, A., Lee, K., Lanske, B., Segre, G.V., Kronenberg, H. M. and Tabin, C.J., Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996; 273: 613-622.
48. Brighton, C.T., Morphology and biochemistry of the growth plate. Rheum Dis Clin North Am 1987; 13: 75-100.
49. Buckwalter, J.A., Mower, D., Ungar, R., Schaeffer, J. and Ginsberg, B., Morphometric analysis of chondrocyte hypertrophy. J Bone Joint Surg Am 1986; 68: 243-255.
50. Bianco, P., Cancedda, F.D., Riminucci, M. and Cancedda, R., Bone formation via cartilage models: the »borderline« chondrocyte. Matrix Biol 1998; 17: 185-192.
51. Hunziker, E.B., Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc Res Tech 1994; 28: 505-519.
52. Storm, E. E. and Kingsley, D.M., Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 1996; 122: 3969-3979.
53. King, J.A., Storm, E.E., Marker, P.C., Dileone, R. J. and Kingsley, D.M., The role of BMPs and GDFs in development of region-specific skeletal structures. Ann NY Acad Sci 1996; 785: 70-79.
54. Horton, W. A. and Hecht, J.T., The skeletal dysplasias: disorders involving cartilage matrix proteins. In Nelson Textbook of Pediatrics (16th edn), Behrman, R.E., Kliegman, R. M. and Jenson, H. B. (Eds). W.B. Saunders: Philadelphia, 2000, pp. 2116-2120.
55. Horton, W. A. and Hecht, J.A., Chondrodysplasias, part II. Disorders involving cartilage matrix proteins. In Extracellular Matrix and Heritable Disorders of Connective Tissue (2nd edn), Royce, P. M. and Steinmann, B. (Eds). Alan R. Liss: New York, 2002.
56. Vandenberg, P., Khillan, J.S., Prockop, D.J., Helminen, H., Kontusaari, S. and Ala-Kokko, L., Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc Natl Acad Sci USA 1991; 88: 7640-7644.
57. Garofalo, S., Vuorio, E., Metsaranta, M., Rosati, R., Toman, D., Vaughan, J., Lozano, G., Mayne, R., Ellard, J., Horton, W. and et al., Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-tocysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci USA 1991; 88: 9648-9652.
58. Metsaranta, M., Garofalo, S., Decker, G., Rintala, M., de Crombrugghe, B. and Vuorio, E., Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J Cell Biol 1992; 118: 203-212.
59. Maddox, B.K., Garofalo, S., Smith, C., Keene, D. R. and Horton, W.A., Skeletal development in transgenic mice expressing a mutation at Gly574Ser of type II collagen. Dev Dyn 1997; 208: 170-177.
60. Li, S.W., Prockop, D.J., Helminen, H., Fassler, R., Lapvetelainen, T., Kiraly, K., Peltarri, A., Arokoski, J., Lui, H., Arita, M. and et al., Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev 1995; 9: 2821-2830.
61. Aszodi, A., Chan, D., Hunziker, E., Bateman, J. F. and Fassler, R., Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. J Cell Biol 1998; 143: 1399-1412.
62. Myllyharju, J. and Kivirikko, K.I., Collagens and collagen-related diseases. Ann Med 2001; 33: 7-21.
63. Kronenberg, H.M., Developmental regulation of the growth plate. Nature 2003; 423: 332-336.
64. Floyd, W.E., 3rd, Zaleske, D.J., Schiller, A.L., Trahan, C. and Mankin, H.J., Vascular events associated with the appearance of the secondary center of ossification in the murine distal femoral epiphysis. J Bone Joint Surg Am 1987; 69: 185-190.
65. Horton, W.A., Skeletal development: insights from targeting the mouse genome. Lancet 2003; 362: 560-569.
66. Chung, U.I., Schipani, E., McMahon, A. P. and Kronenberg, H.M., Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest 2001; 107: 295-304.
67. Long, F., Zhang, X.M., Karp, S., Yang, Y. and McMahon, A.P., Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 2001; 128: 5099-5108.
68. Karp, S.J., Schipani, E., St-Jacques, B., Hunzelman, J., Kronenberg, H. and McMahon, A.P., Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and-independent pathways. Development 2000; 127: 543-548.
69. Schipani, E., Kruse, K. and Juppner, H., A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995; 268: 98-100.
70. Jobert, A.S., Zhang, P., Couvineau, A., Bonaventure, J., Roume, J., Le Merrer, M. and Silve, C., Absence of functional receptors for parathyroid hormone and parathyroid hormonerelated peptide in Blomstrand chondrodysplasia. J Clin Invest 1998; 102: 34-40.
71. Chuang, P. T. and McMahon, A.P., Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 1999; 397: 617-621.
72. Minina, E.,Wenzel, H.M., Kreschel, C., Karp, S., Gaffield, W., McMahon, A. P. and Vortkamp, A., BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 2001; 128: 4523-4534.
73. Minina, E., Kreschel, C., Naski, M.C., Ornitz, D. M. and Vortkamp, A., Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev Cell 2002; 3: 439-449.
74. Seki, K. and Hata, A., Indian hedgehog gene is a target of the bone morphogenetic protein signaling pathway. J Biol Chem 2004; 279: 18544-18549.
75. Colvin, J.S., Bohne, B.A., Harding, G.W., McEwen, D. G. and Ornitz, D.M., Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 1996; 12: 390-397.
76. Deng, C.,Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P., Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996; 84: 911-921.
77. Shiang, R., Thompson, L.M., Zhu, Y.Z., Church, D.M., Fielder, T.J., Bocian, M., Winokur, S. T. and Wasmuth, J.J., Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994; 78: 335-342.
78. Tavormina, P.L., Shiang, R., Thompson, L.M., Zhu, Y.Z., Wilkin, D.J., Lachman, R.S., Wilcox, W.R., Rimoin, D.L., Cohn, . H. andWasmuth, J.J., Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995; 9: 321-328.
79. Bellus, G.A., McIntosh, I., Smith, E.A., Aylsworth, A.S., Kaitila, I., Horton, W.A., Greenhaw, G.A., Hecht, J. T. and Francomano, C.A., A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet 1995; 10: 357-359.
80. Naski, M.C., Colvin, J.S., Coffin, J. D. and Ornitz, D.M., Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 1998; 125: 4977-4988.
81. Chen, L., Adar, R., Yang, X., Monsonego, E.O., Li, C., Hauschka, P.V., Yayon, A. and Deng, C.X., Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 1999; 104: 1517-1525.
82. Garofalo, S., Kliger-Spatz, M., Cooke, J.L., Wolstin, O., Lunstrum, G.P., Moshkovitz, S.M., Horton, W. A. and Yayon, A., Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice. J Bone Miner Res 1999; 14: 1909-1915.
83. Iwata, T., Chen, L., Li, C., Ovchinnikov, D.A., Behringer, R.R., Francomano, C. A. and Deng, C.X., A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum Mol Genet 2000; 9: 1603-1613.
84. Kanai, M., Goke, M., Tsunekawa, S. and Podolsky, D.K., Signal transduction pathway of human fibroblast growth factor receptor . Identification of a novel 66-kDa phosphoprotein. J Biol Chem 1997; 272: 6621-6628.
85. Sahni, M., Ambrosetti, D.C., Mansukhani, A., Gertner, R., Levy, D. and Basilico, C., FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 1999; 13: 1361-1366.
86. Su, W.C., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A. and Fu, X.Y., Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 1997; 386: 288-292.
87. Yasoda, A., Komatsu, Y., Chusho, H., Miyazawa, T., Ozasa, A., Miura, M., Kurihara, T., Rogi, T., Tanaka, S., Suda, M., Tamura, N., Ogawa, Y. and Nakao, K., Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 2004; 10: 80-86.
88. Murakami, S., Balmes, G., McKinney, S., Zhang, Z., Givol, D. and de Crombrugghe, B., Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 2004; 18: 290-305.
89. Liu, Z., Xu, J., Colvin, J. S. and Ornitz, D.M., Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 2002; 16: 859-869.
90. Murakami, S., Kan, M., McKeehan, W. L. and de Crombrugghe, B., Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 2000; 97: 1113-1118.
91. Huang, W., Zhou, X., Lefebvre, V. and de Crombrugghe, B., Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol 2000; 20: 4149-4158.
92. Nakao, K., Ogawa, Y., Suga, S. and Imura, H., Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. J Hypertens 1992; 10: 1111-1114.
93. Nakao, K., Ogawa, Y., Suga, S. and Imura, H., Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J Hypertens 1992; 10: 907-912.
94. Chusho, H., Tamura, N., Ogawa, Y., Yasoda, A., Suda, M., Miyazawa, T., Nakamura, K., Nakao, K., Kurihara, T., Komatsu, Y., Itoh, H., Tanaka, K., Saito, Y. and Katsuki, M., Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 2001; 98: 4016-4021.
95. Vu, T.H., Shipley, J.M., Bergers, G., Berger, J.E., Helms, J.A., Hanahan, D., Shapiro, S.D., Senior, . M. andWerb, Z.,MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998; 93: 411-422.
96. Zelzer, E., Glotzer, D.J., Hartmann, C., Thomas, D., Fukai, N., Soker, S. and Olsen, B.R., Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 2001; 106: 97-106.
97. Schipani, E., Ryan, H.E., Didrickson, S., Kobayashi, T., Knight, M. and Johnson, R.S., Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 2001; 15: 2865-2876.
98. Ivkovic, S., Yoon, B.S., Popoff, S.N., Safadi, F.F., Libuda, D.E., Stephenson, R.C., Daluiski, A. and Lyons, K.M., Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003; 130: 2779-2791.
99. Gleizes, P.E., Munger, J.S., Nunes, I., Harpel, J.G., Mazzieri, R., Noguera, I. and Rifkin, D.B., TGF-beta latency: biological significance and mechanisms of activation. Stem Cells 1997; 15: 190-197.
100. Pedrozo, H.A., Schwartz, Z., Gomez, R., Ornoy, A., Xin-Sheng, W., Dallas, S.L., Bonewald, L.F., Dean, D. D. and Boyan, B.D., Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1. J Cell Physiol 1998; 177: 343-354.
101. D'Angelo, M., Sarment, D.P., Billings, P. C. and Pacifici, M., Activation of transforming growth factor beta in chondrocytes undergoing endochondral ossification. J Bone Miner Res 2001; 16: 2339-2347.
102. Hagenas, L. and Hertel, T., Skeletal dysplasia, growth hormone treatment and body proportion: comparison with other syndromic and non-syndromic short children. Horm Res 2003; 60(Suppl. 3): 65-70.
103. Wang, J., Zhou, J., Cheng, C.M., Kopchick, J. J. and Bondy, C.A., Evidence supporting dual, IGF-I-independent and IGFI-dependent, roles for GH in promoting longitudinal bone growth. J Endocrinol 2004; 180: 247-255.
104. Ilizarov, G.A., Clinical application of the tension-stress effect for limb lengthening. Clin Orthop 1990; 250: 8-26.
105. Vilarrubias, J.M., Ginebreda, I. and Fernandez-Fairen, M., (500 cases of lower limb lengthening using a personal technique in achondroplasia). Acta Orthop Belg 1988; 54: 384-390.
106. Paley, D., Current techniques of limb lengthening. J Pediatr Orthop 1988; 8: 73-92.
107. Aviezer, D., Golembo, M. and Yayon, A., Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia-genetic short limbed dwarfism. Curr Drug Targets 2003; 4: 353-365.
108. Plotnikov, A.N., Schlessinger, J., Hubbard, S. R. and Mohammadi, M., Structural basis for FGF receptor dimerization and activation. Cell 1999; 98: 641-650.
109. Hart, K.C., Robertson, S. C. and Donoghue, D.J., Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. Mol Biol Cell 2001; 12: 931-942.
110. Ornitz, D. M. and Marie, P.J., FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 2002; 16: 1446-1465.
111. Horton, W.A., Fibroblast growth factor receptor 3 and the human chondrodysplasias. Curr Opin Pediatr 1997; 9: 437-442.
112. Cho, J.Y., Guo, C., Torello, M., Lunstrum, G.P., Iwata, T., Deng, C. and Horton, W.A., Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. Proc Natl Acad Sci USA 2004; 101: 609-614.
113. Rauchenberger, R., Borges, E., Thomassen-Wolf, E., Rom, E., Adar, R., Yaniv, Y., Malka, M., Chumakov, I., Kotzer, S., Resnitzky, D., Knappik, A., Reiffert, S., Prassler, J., Jury, K.,Waldherr, D., Bauer, S., Kretzschmar, T., Yayon, A. and Rothe, C., Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3. J Biol Chem 2003; 278: 38194-38205.
114. Suda, M., Ogawa, Y., Tanaka, K., Tamura, N., Yasoda, A., Takigawa, T., Uehira, M., Nishimoto, H., Itoh, H., Saito, Y., Shiota, K. and Nakao, K., Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci USA 1998; 95: 2337-2342.